AIM:- A randomized non-inferiority trial comparing low dose albumin versus standard dose albumin in Spontaneous Bacterial Peritonitis with acute kidney injury
Methodology In this non-inferior randomized controlled trial one group will receive Low dose albumin: 20% albumin.5 g/kg at diagnosis and 0.5 g/kg till 5 days and other group will receive Standard dose albumin: 20% albumin1.5 g/kg at diagnosis and 1 g/kg at 48 h (duration of infusion 24 hours).
Study population: Patients of age > 18 years of age with cirrhosis of liver who are admitted in ward/Intensive Care Unit diagnosed with Spontaneous Bacterial Peritonitis.
Study design: Randomized controlled trial Study period: September 2019- September 2020 Sample size: 300 (150 cases in each group) If there is a true difference in favour of the experimental treatment of 5 % then 270 patients are required to be 80% sure that the upper limit of a one sided 95% confidence interval (or equivalently a 90 % two-sided confidence interval) will exclude a difference in favour of the standard group of more than 5 %. And if the investigators consider 10% drop out final sample size is 270+30=300. 150 in each limb. Cases will be randomly allocated in 2 groups by block randomization method with block size taken as 10.
Monitoring and assessment: all the parameters of the objective and also noted any adverse effects.
Adverse Effects: Nausea, Vomiting, Fever with chills, dyspnea Stopping Rule: in the event of any of the adverse effects during therapy.
Expected Outcome of the project:
Proportion of patients having progression of Acute Kidney Injury by day 7
Condition | Spontaneous Bacterial Peritonitis |
---|---|
Treatment | Low Dose Albumin, Standard dose Albumin |
Clinical Study Identifier | NCT04273373 |
Sponsor | Institute of Liver and Biliary Sciences, India |
Last Modified on | 8 March 2021 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.